Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study

BACKGROUND: High budget impact (BI) estimates of new drugs limit access to patients due to concerns regarding affordability and displacement effects. The accuracy and methodological quality of BI analyses are often low, potentially mis-informing reimbursement decision making. Using hepatitis C as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Geenen, Joost W., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652171/
https://www.ncbi.nlm.nih.gov/pubmed/30953216
http://dx.doi.org/10.1007/s10198-019-01048-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652171/
https://www.ncbi.nlm.nih.gov/pubmed/30953216
http://dx.doi.org/10.1007/s10198-019-01048-z

Ejemplares similares